[go: up one dir, main page]

MX366649B - Composiciones transdérmicas de propinilaminoindan. - Google Patents

Composiciones transdérmicas de propinilaminoindan.

Info

Publication number
MX366649B
MX366649B MX2015004858A MX2015004858A MX366649B MX 366649 B MX366649 B MX 366649B MX 2015004858 A MX2015004858 A MX 2015004858A MX 2015004858 A MX2015004858 A MX 2015004858A MX 366649 B MX366649 B MX 366649B
Authority
MX
Mexico
Prior art keywords
transdermal compositions
propynylaminoindan
propynylaminoindan transdermal
compositions
rasagiline
Prior art date
Application number
MX2015004858A
Other languages
English (en)
Other versions
MX2015004858A (es
Inventor
Jianye Wen
Richard D Hamlin
Amit Jain
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Publication of MX2015004858A publication Critical patent/MX2015004858A/es
Publication of MX366649B publication Critical patent/MX366649B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan composiciones transdérmica de propinilaminoindan (por ejemplo, Rasagilina); los aspectos de las composiciones transdérmicas incluyen una matriz que incluye el propinilaminoindan, un adhesivo sensible a la presión que incluye un copolímero de acrilato y un copolímero acrílico catiónico; también se proporcionan métodos de uso de las composiciones transdérmicas y kits que contienen las composiciones transdérmicas.
MX2015004858A 2012-11-02 2013-10-25 Composiciones transdérmicas de propinilaminoindan. MX366649B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261722044P 2012-11-02 2012-11-02
PCT/US2013/066964 WO2014070622A1 (en) 2012-11-02 2013-10-25 Propynylaminoindan transdermal compositions

Publications (2)

Publication Number Publication Date
MX2015004858A MX2015004858A (es) 2015-07-21
MX366649B true MX366649B (es) 2019-07-17

Family

ID=50622582

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015004858A MX366649B (es) 2012-11-02 2013-10-25 Composiciones transdérmicas de propinilaminoindan.

Country Status (16)

Country Link
US (3) US9205061B2 (es)
EP (1) EP2914249B1 (es)
JP (1) JP6050896B2 (es)
KR (2) KR20150059177A (es)
CN (1) CN104797245B (es)
AR (1) AR093329A1 (es)
AU (1) AU2013338243B2 (es)
BR (1) BR112015007872A2 (es)
CA (1) CA2887705C (es)
EA (1) EA031621B1 (es)
IL (1) IL238381B (es)
MX (1) MX366649B (es)
NZ (1) NZ706590A (es)
SG (1) SG11201502681WA (es)
TW (1) TWI543782B (es)
WO (1) WO2014070622A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2615774B2 (ja) 1988-03-09 1997-06-04 株式会社豊田自動織機製作所 織機における不要緯糸排出方法
NZ706590A (en) 2012-11-02 2016-02-26 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
US20170189347A1 (en) * 2014-06-24 2017-07-06 KAT Transdermals LLC Transdermal delivery system
KR102155108B1 (ko) * 2019-11-27 2020-09-11 주식회사 우신라보타치 라사길린 또는 그의 약학적으로 허용가능한 염을 함유하는 경피흡수제제
CN116036055A (zh) * 2023-03-16 2023-05-02 上海世领制药有限公司 一种含甲磺酸雷沙吉兰的透皮贴剂及其制备方法

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588740A (en) 1982-12-07 1986-05-13 Smithkline Beckman Corporation Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones
US4452808A (en) 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
JPS61280426A (ja) 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
GB8712073D0 (en) 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
DE69009540T2 (de) 1989-03-15 1994-09-29 Nitto Denko Corp Arzneimittel enthaltendes Heftpflaster.
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
IL92952A (en) 1990-01-03 1994-06-24 Teva Pharma R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
JP2849937B2 (ja) 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
EP0593807A1 (en) 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
US5462746A (en) 1992-11-02 1995-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
JP2539330B2 (ja) 1993-05-11 1996-10-02 日東電工株式会社 医療用粘着剤及びこれを用いて形成された医療用外用材
US5914349A (en) 1994-01-10 1999-06-22 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
US5391406A (en) 1994-03-25 1995-02-21 National Starch And Chemical Investment Holding Corporation Process of preparing hot melt pressure sensitive adhesives on a substrate
JP3604177B2 (ja) 1994-09-14 2004-12-22 日東電工株式会社 経皮吸収製剤
JP3576608B2 (ja) 1994-11-15 2004-10-13 日東電工株式会社 貼付剤および貼付製剤
IL122484A0 (en) 1995-06-07 1998-06-15 Noven Pharma Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
IL115357A (en) 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
US5807570A (en) 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
DE19628999C1 (de) 1996-07-18 1998-03-12 Lohmann Gmbh & Co Kg Medizinische Haftklebstoffe mit hoher Wasserdampfdurchlässigkeit und Klebkraft und damit versehene Pflaster und ihre Verwendung
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
US6132761A (en) 1997-09-05 2000-10-17 Nitto Denko Corporation Percutaneous absorption preparation
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
IL135258A0 (en) 1997-09-26 2001-05-20 Noven Pharma Bioadhesive compositions and methods for topical administration of active agents
US6809120B1 (en) 1998-01-13 2004-10-26 University Of Saskatchewan Technologies Inc. Composition containing propargylamine for enhancing cancer therapy
US6146656A (en) 1998-01-22 2000-11-14 Nitto Denko Corporation Percutaneous absorption preparation
DE19814087A1 (de) 1998-03-30 1999-10-14 Lohmann Therapie Syst Lts Feuchtigkeitsaktivierbares therapeutisches System
US6596945B1 (en) 1998-09-11 2003-07-22 Southwire Company Superconducting cable
DE69916424T2 (de) 1998-12-02 2005-05-19 Nichiban Co. Ltd. Druckempfindliches klebeband zur befestigung auf der haut und grundmaterial zu seiner benutzung
NZ525878A (en) 1998-12-07 2004-12-24 Elan Pharma Int Ltd A method of treating nicotine dependance with mecamylamine
DE19918106A1 (de) 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
US6218421B1 (en) 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
DE19950066A1 (de) 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
WO2001052823A2 (en) 2000-01-20 2001-07-26 Noven Pharmaceuticals, Inc. Compositions to effect the release profile in the transdermal administration of drugs
US6277875B1 (en) 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
DE10035891A1 (de) 2000-07-24 2002-02-14 Lohmann Therapie Syst Lts Medizinischer Haftkleber mit einer zweiphasigen Klebermatrix aus Polyacrylaten und Polyaminsalzen
US20070225379A1 (en) 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US20040028724A1 (en) 2000-11-07 2004-02-12 Takaaki Terahara Pharmaceutical preparation of percutaneous absorption type
DE10060852A1 (de) 2000-12-06 2002-06-20 Hexal Ag Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems
WO2002069974A1 (en) 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
US20030212085A1 (en) 2001-04-17 2003-11-13 Mccall Robert B. Treatment of fibromyalgia and chronic fatigue syndrome
DE10137162A1 (de) 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
US20050186141A1 (en) 2002-06-25 2005-08-25 Acrux Dds Pty Ltd. Transdermal aerosol compositions
JP5160018B2 (ja) 2002-06-25 2013-03-13 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド 非晶質医薬組成物を用いる経皮送達速度調節
EP1386605A1 (en) 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system for the administration of rotigotine
WO2004045515A2 (en) 2002-11-15 2004-06-03 Teva Pharmaceutical Industries, Ltd. Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
AR044007A1 (es) 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
US20040242669A1 (en) 2003-05-27 2004-12-02 Filippo Drago Method of treating deficits associated with brain injury
WO2005009417A1 (en) 2003-07-21 2005-02-03 Noven Pharmaceuticals, Inc. Composition and method for controlling grug delivery from silicone adhesive blends
DE10338174A1 (de) 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
BRPI0414551B8 (pt) 2003-10-10 2021-05-25 Antares Pharma Ipl Ag formulação farmacêutica transdérmica ou transmucosa e método de protelação ou inibição da cristalização de um agente ativo
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US7378439B2 (en) 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
KR20060124731A (ko) 2004-01-29 2006-12-05 뉴로몰레큘라 파마슈티칼스, 인코포레이티드 중추신경계-관련 질환 치료용 ｎｍｄａ 수용체 길항제 및ｍａｏ-억제제 또는 ｇａｄｐｈ-억제제의 배합물
JP2005232148A (ja) 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用
EP1742624B1 (en) 2004-02-18 2010-01-06 Sepracor, Inc. Dopamine-agonist combination therapy with sedatives for improving sleep quality
US20080226697A1 (en) 2004-04-21 2008-09-18 Hisamitsu Pharmaceutical Co., Inc. Patch for External Use with Elevated Content of Absorption Promoter in Pressure-Sensitive Adhesive Base
ITMI20041628A1 (it) 2004-08-06 2004-11-06 Bouty S P A Sistema terapeutico a rilascio controllato per uso topico transdermico
WO2006028863A1 (en) * 2004-09-01 2006-03-16 Nexmed Holdings, Inc. Transdermal antiemesis delivery system, method and composition therefor
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
TW200628175A (en) 2004-10-08 2006-08-16 Noven Pharma Transdermal drug delivert device including an occlusive backing
WO2006120577A1 (en) 2005-02-22 2006-11-16 Teva Pharmaceutical Industries Ltd. Improved process for the synthesis of enantiomeric indanylamine derivatives
KR20180026580A (ko) 2005-02-23 2018-03-12 테바 파마슈티컬 인더스트리즈 리미티드 함량 균일성이 개선된 라사길린 제형
US20070078172A1 (en) 2005-06-16 2007-04-05 Jenrin Discovery Mao-b inhibitors useful for treating obesity
US20070134310A1 (en) 2005-09-23 2007-06-14 Nedberge Diane E Transdermal risperidone delivery system
KR100663163B1 (ko) 2005-10-24 2007-01-02 (주)아모레퍼시픽 비스테로이드성 소염진통제를 함유하는 경피 투여 제제
US7491847B2 (en) 2005-11-17 2009-02-17 Teva Pharmaceutical Industries, Ltd. Methods for isolating propargylated aminoindans
US7572834B1 (en) 2005-12-06 2009-08-11 Teva Pharmaceutical Industries, Ltd. Rasagiline formulations and processes for their preparation
JP5037831B2 (ja) * 2006-02-15 2012-10-03 久光製薬株式会社 凝集力向上及び徐放化の外用貼付剤
CN101032474B (zh) 2006-03-06 2011-02-16 重庆医药工业研究院有限责任公司 一种治疗或预防神经系统疾病的雷沙吉兰透皮贴片及其制备方法
NZ572206A (en) 2006-03-24 2012-02-24 Auxilium Int Holdings Inc Process for the preparation of a hot-melt extruded laminate
RU2008144405A (ru) 2006-04-11 2010-05-20 Нитибан Ко, Лтд (Jp) Содержащий тамсулозин трансдермальный пластырь
US20070254941A1 (en) 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
TW200815045A (en) 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
CA2667477C (en) 2006-10-27 2015-12-08 Noven Pharmaceuticals, Inc. Transdermal delivery of ketoprofen polar derivatives
JP5623081B2 (ja) 2006-12-14 2014-11-12 テバ ファーマシューティカル インダストリーズ リミティド 結晶質固体のラサジリン塩基
AU2007338631A1 (en) * 2006-12-22 2008-07-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
US20090043111A1 (en) 2007-08-06 2009-02-12 Meizheng Liu Novel process for ropinirole preparation
DE102007041557B4 (de) 2007-08-29 2011-03-31 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend längliche Hohlkörper
JP2010538067A (ja) 2007-09-05 2010-12-09 テバ ファーマシューティカル インダストリーズ リミティド ラサギリンを使用する緑内障の治療方法
US8188149B2 (en) 2007-09-17 2012-05-29 Teva Pharmaceutical Industries, Ltd. Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
KR100929560B1 (ko) 2008-01-09 2009-12-03 에코 퍼시픽 엘티디 그라니세트론을 함유한 매트릭스 형태의 경피 흡수제
WO2009107476A1 (ja) 2008-02-27 2009-09-03 久光製薬株式会社 貼付製剤
WO2009139411A1 (ja) 2008-05-15 2009-11-19 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤
US20090291127A1 (en) 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
WO2009154777A2 (en) 2008-06-19 2009-12-23 Teva Pharmaceutical Industries, Ltd. Process for preparing and drying solid rasagiline base
JP2011525489A (ja) 2008-06-19 2011-09-22 テバ ファーマシューティカル インダストリーズ リミティド ラサリジン塩基の精製方法
CN101606923B (zh) 2008-06-20 2013-01-09 重庆医药工业研究院有限责任公司 一种稳定的控释释放的雷沙吉兰透皮贴片及其制备方法
WO2010008600A1 (en) 2008-07-16 2010-01-21 Dermworx Incorporated Topical drug delivery system
US20100029987A1 (en) 2008-07-29 2010-02-04 Dipharma Francis S.R.I. Crystalline Form of Rasagiline and Process for the Preparation Thereof
US20100087768A1 (en) 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
WO2011005853A2 (en) 2009-07-08 2011-01-13 Msk Pharma, Llc Compositions and methods of topical drug delivery for the treatment of carpal tunnel syndrome
JP5675225B2 (ja) 2009-09-01 2015-02-25 久光製薬株式会社 貼付製剤
EP2298277A1 (en) 2009-09-09 2011-03-23 Labtec GmbH Transdermal patch formulation
CN102100682A (zh) 2009-12-16 2011-06-22 重庆医药工业研究院有限责任公司 一种高生物利用度的缓释长效雷沙吉兰透皮贴片及其制备方法
EA023786B1 (ru) 2010-04-30 2016-07-29 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Трансдермальные композиции на основе пропиниламиноиндана
CN102475692A (zh) 2010-11-29 2012-05-30 重庆医药工业研究院有限责任公司 一种防止雷沙吉兰挥发的透皮贴片
KR101853082B1 (ko) * 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
NZ706590A (en) 2012-11-02 2016-02-26 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions

Also Published As

Publication number Publication date
AU2013338243A1 (en) 2015-04-23
TWI543782B (zh) 2016-08-01
CN104797245A (zh) 2015-07-22
EA201590489A1 (ru) 2016-02-29
US9827207B2 (en) 2017-11-28
IL238381B (en) 2019-12-31
US20140186422A1 (en) 2014-07-03
CA2887705C (en) 2018-07-24
CA2887705A1 (en) 2014-05-08
EP2914249B1 (en) 2020-06-17
HK1207558A1 (en) 2016-02-05
JP6050896B2 (ja) 2016-12-21
AU2013338243B2 (en) 2016-09-29
TW201431571A (zh) 2014-08-16
US9205061B2 (en) 2015-12-08
JP2015535284A (ja) 2015-12-10
SG11201502681WA (en) 2015-05-28
BR112015007872A2 (pt) 2017-07-04
EA031621B1 (ru) 2019-01-31
EP2914249A4 (en) 2016-05-11
EP2914249A1 (en) 2015-09-09
US10918607B2 (en) 2021-02-16
IL238381A0 (en) 2015-06-30
US20140127281A1 (en) 2014-05-08
KR20170091791A (ko) 2017-08-09
US20160051489A1 (en) 2016-02-25
WO2014070622A1 (en) 2014-05-08
KR101856515B1 (ko) 2018-05-10
KR20150059177A (ko) 2015-05-29
MX2015004858A (es) 2015-07-21
NZ706590A (en) 2016-02-26
AR093329A1 (es) 2015-06-03
CN104797245B (zh) 2018-05-04

Similar Documents

Publication Publication Date Title
SG10201900693TA (en) Pressure-sensitive adhesive sheet
PH12012501777A1 (en) Propynylaminoindan transdermal compositions
MY177183A (en) Water-dispersed pressure-sensitive adhesive composition and pressure-sensitive adhesive
MX2018006268A (es) Reticulacion de polimero termicamente reversible para adhesivos sensibles a la presion.
EP3252090A4 (en) Acrylic block copolymer and pressure-sensitive adhesive composition
EP3075753A4 (en) (METH) ACRYLIC POLYMER, LABEL COMPOSITION THEREFOR AND ADHESIVE
EP3122833A4 (en) Ultraviolet cured (meth)acrylate pressure-sensitive adhesive composition and process for producing thereof
MX2015004606A (es) Adhesivos y metodos relacionados.
SG11201609552QA (en) Hydrogenated block copolymer composition and pressure-sensitive adhesive composition
MY188161A (en) Pressure sensitive adhesive compositions and methods for preparing same
SG11201500419WA (en) Block copolymer composition for adhesives, and adhesive composition
EP3190156A4 (en) Curable silicone composition, curable hot-melt silicone, and optical device
MY168166A (en) Polymer and Composition Including Same, and Adhesive Composition
IN2015DN02237A (es)
EP3127931A4 (en) Urethane (meth)acrylate compound, active-energy-ray-curable resin composition, and coating agent
NZ706590A (en) Propynylaminoindan transdermal compositions
MX2017014000A (es) Adhesivos acrilicos en emulsion.
EP3390568A4 (en) SILICON ADHESIVE COMPOSITION
EP3315574A4 (en) Pressure-sensitive adhesive and pressure-sensitive adhesive sheet
EP3120993A4 (en) Method for affixing adhesive sheet, and device for affixing adhesive sheet
EP3202844A4 (en) Block copolymer composition, adhesive composition, and adhesive sheet
EP3193208A4 (en) Diffusion plate supporting piece and backlight module
PH12016502331A1 (en) Novel compounds
EP3408341A4 (en) AUTOCOLLATING ADHESIVE COMPOSITION
EP3260509A4 (en) 2-cyanoacrylate adhesive composition

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: TEIKOKU SEIYAKU CO., LTD.